Skip to main content
Clinical Trials/JPRN-UMIN000028152
JPRN-UMIN000028152
Not yet recruiting
未知

Risk factors for diabetes induced by immune checkpoint inhibitor - Study on diabetes induced immune checkpoint inhibitor

Toranomon Hospital Department of Endocrinology and Metabolism.0 sites50 target enrollmentJuly 31, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Toranomon Hospital Department of Endocrinology and Metabolism.
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 31, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Toranomon Hospital Department of Endocrinology and Metabolism.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients judged inappropriate to 75g oral glucose tolerance test. 2\)Patients who are pregnant, hope to be pregnant, or are in lactation period. 3\)Patients judged inappropriate to participate in this research by doctors.

Outcomes

Primary Outcomes

Not specified

Similar Trials